{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:57:46Z","timestamp":1788512266388,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13555-016-0115-8","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T04:43:30Z","timestamp":1460781810000},"page":"251-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation"],"prefix":"10.1007","volume":"6","author":[{"given":"Hasan H.","family":"Danish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thatcher R.","family":"Heumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Switchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natia","family":"Esiashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Lechowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad K.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,16]]},"reference":[{"issue":"11","key":"115_CR1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","volume":"149","author":"K Korgavkar","year":"2013","unstructured":"Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA dermatology. 2013;149(11):1295\u20139.","journal-title":"JAMA dermatology."},{"issue":"4","key":"115_CR2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/10428194.2012.729831","volume":"54","author":"MH Imam","year":"2013","unstructured":"Imam MH, Shenoy PJ, Flowers CR, Phillips A, Lechowicz MJ. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma. 2013;54(4):752\u20139.","journal-title":"Leuk Lymphoma."},{"issue":"5","key":"115_CR3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archdermatol.2011.98","volume":"147","author":"D Navi","year":"2011","unstructured":"Navi D, Riaz N, Levin YS, Sullivan NC, Kim YH, Hoppe RT. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides. Arch Dermatol. 2011;147(5):561\u20137.","journal-title":"Arch Dermatol"},{"issue":"7","key":"115_CR4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","volume":"119","author":"MF Benner","year":"2012","unstructured":"Benner MF, Jansen PM, Vermeer MH, Willemze R. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood. 2012;119(7):1643\u20139.","journal-title":"Blood"},{"issue":"12","key":"115_CR5","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","volume":"33","author":"JT Edinger","year":"2009","unstructured":"Edinger JT, Clark BZ, Pucevich BE, Geskin LJ, Swerdlow SH. CD30 expression and proliferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol. 2009;33(12):1860\u20138.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"115_CR6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2013.04.042","volume":"86","author":"SL Morris","year":"2013","unstructured":"Morris SL, McGovern M, Bayne S, Wain M, Child F, Whittaker S. Results of a 5-week schedule of modern total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86(5):936\u201341.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"115_CR7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-4632.2005.02217.x","volume":"44","author":"DK Parida","year":"2005","unstructured":"Parida DK, Verma KK, Chander S, Joshi RC, Rath GK. Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: a preliminary experience. Int J Dermatol. 2005;44(10):828\u201330.","journal-title":"Int J Dermatol"},{"issue":"5","key":"115_CR8","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1111\/j.1365-2230.2008.03128.x","volume":"34","author":"DK Parida","year":"2009","unstructured":"Parida DK, Verma KK, Rath GK. Total skin electron irradiation treatment for mycosis fungoides with a new alternate daily treatment schedule to minimize radiation-associated toxicity: a preliminary experience. Clin Exp Dermatol. 2009;34(5):e37\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"115_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/bjd.12386","volume":"169","author":"AE Wagner","year":"2013","unstructured":"Wagner AE, Wada D, Bowen G, Gaffney DK. Mycosis fungoides: the addition of concurrent and adjuvant interferon to total skin electron beam therapy. Br J Dermatol. 2013;169(3):715\u20138.","journal-title":"Br J Dermatol."},{"issue":"4","key":"115_CR10","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ijrobp.2003.08.007","volume":"58","author":"L Ysebaert","year":"2004","unstructured":"Ysebaert L, Truc G, Dalac S, Lambert D, Petrella T, Barillot I, et al. Ultimate results of radiation therapy for T1\u2013T2 mycosis fungoides (including reirradiation). Int J Radiat Oncol Biol Phys. 2004;58(4):1128\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"115_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0167-8140(92)90374-4","volume":"24","author":"CR Freeman","year":"1992","unstructured":"Freeman CR, Suissa S, Shenouda G, Vuong T, Souhami L, Pla M, et al. Clinical experience with a single field rotational total skin electron irradiation technique for cutaneous T-cell lymphoma. Radiother Oncol. 1992;24(3):155\u201362.","journal-title":"Radiother Oncol"},{"issue":"1","key":"115_CR12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijrobp.2014.11.033","volume":"92","author":"TR Heumann","year":"2015","unstructured":"Heumann TR, Esiashvili N, Parker S, Switchenko JM, Dhabbaan A, Goodman M, et al. Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique. Int J Radiat Oncol Biol Phys. 2015;92(1):183\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"115_CR13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00000421-198708000-00018","volume":"10","author":"PP Kumar","year":"1987","unstructured":"Kumar PP, Good RR, Jones EO, McAnulty BE, Reeves MA. Dual-field rotational (DFR) technique for total-skin electron-beam therapy (TSEBT). Am J Clin Oncol. 1987;10(4):344\u201354.","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"115_CR14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713\u201322.","journal-title":"Blood"},{"issue":"31","key":"115_CR15","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","volume":"28","author":"NS Agar","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, et al. Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28(31):4730\u20139.","journal-title":"J Clin Oncol"},{"issue":"13","key":"115_CR16","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","volume":"49","author":"EC Benton","year":"2013","unstructured":"Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, Wedgeworth E, et al. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome. Eur J Cancer. 2013;49(13):2859\u201368.","journal-title":"Eur J Cancer"},{"issue":"18","key":"115_CR17","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","volume":"18","author":"R Talpur","year":"2012","unstructured":"Talpur R, Singh L, Daulat S, Liu P, Seyfer S, Trynosky T, et al. Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009. Clinical Cancer Res. 2012;18(18):5051\u201360.","journal-title":"Clinical Cancer Res"},{"issue":"32","key":"115_CR18","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","volume":"33","author":"JJ Scarisbrick","year":"2015","unstructured":"Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, et al. Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and Sezary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol. 2015;33(32):3766\u201373.","journal-title":"J Clin Oncol"},{"issue":"7","key":"115_CR19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/PAT.0000000000000166","volume":"46","author":"M Pulitzer","year":"2014","unstructured":"Pulitzer M, Myskowski PL, Horwitz SM, Querfeld C, Connolly B, Li J, et al. Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors. Pathology. 2014;46(7):610\u20136.","journal-title":"Pathology."},{"issue":"32","key":"115_CR20","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2014.60.3969","volume":"33","author":"YH Kim","year":"2015","unstructured":"Kim YH, Tavallaee M, Sundram U, Salva KA, Wood GS, Li S, et al. Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sezary syndrome with variable CD30 expression level: a multi-institution collaborative project. J Clin Oncol. 2015;33(32):3750\u20138.","journal-title":"J Clin Oncol"},{"issue":"32","key":"115_CR21","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","volume":"33","author":"M Duvic","year":"2015","unstructured":"Duvic M, Tetzlaff MT, Gangar P, Clos AL, Sui D, Talpur R. Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis. J Clin Oncol. 2015;33(32):3759\u201365.","journal-title":"J Clin Oncol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-016-0115-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T11:07:02Z","timestamp":1498302422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-016-0115-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,16]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["115"],"URL":"https:\/\/doi.org\/10.1007\/s13555-016-0115-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,16]]}}}